Shire plc (SHPG) Company Profile
Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. The Company’s products include VYVANSE/VENVANSE/ELVANSE/TYVENSE/ELVANSEVUXEN/ADUVANZ (lisdexamfetamine dimesylate), ADDERALL XR (mixed salts of a single-entity amphetamine), INTUNIV (extended release guanfacine), LIALDA (mesalamine)/MEZAVANT(mesalazine), PENTASA (mesalamine), REPLAGAL (agalsidase alfa), ELAPRASE (idursulfase), VPRIV (velaglucerase alfa), FIRAZYR (icatibant), FOSRENOL (lanthanum carbonate), KALBITOR, CINRYZE C1 esterase inhibitor (human), GATTEX/REVESTIVE, BUMINATE 25% Albumin (Human), BUMINATE 5% Albumin (Human), GLASSIA Alpha1-Proteinase Inhibitor (Human) and ONCASPAR pegaspargase.
News about SHPG
The 3 Best Biotech Stocks to Buy in June 2018
By 2025, the biotech industry will be worth $727 billion – a 120% increase over its total value in 2015. To help you take advantage of the tremendous growth potential, we're bringing you the three best biotech stocks to buy in June. Y...Read More>>>
Can Nektar Therapeutics Disrupt This $20 Billion Market?
If you suffer from chronic back pain, you're not alone. Lower back pain is the second most common cause of disability in the United States and employees miss a combined 149 million days of work every year because of it. Clearly, treatment options for...Read More>>>
Companies have spent a stunning $2 trillion on mergers so far this year
Merger mania is back with a vengeance this year. Companies have announced more than $2 trillion in deals so far in 2018. That's a record pace for merger activity, topping the deal volume from the first few months of 2007, according to Thomson Reuter...Read More>>>
The 3 Best Biotech Stocks to Buy Today
The best biotech stocks to buy today are on sale thanks to a crucial mistake on Wall Street. The industry is on the cusp of a breakout, but Wall Street traders are hunkering down and taking their money with them. But Wall Street's loss can ...Read More>>>
Shire (SHPG) Position Lowered by Eaton Vance Management
Eaton Vance Management lessened its position in shares of Shire (NASDAQ:SHPG) by 14.2% in the 1st quarter, HoldingsChannel reports. The fund owned 34,102 shares of the biopharmaceutical company’s stock after selling 5,638 shares during the per...Read More>>>